{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:59:44Z","timestamp":1785517184959,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009734","name":"Olympus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In this study, we investigated the diagnostic performance of magnifying endoscopy (ME) with third-generation narrow-band imaging (3G-NBI) for early gastric cancer (EGC), primarily in patients with\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      eradication.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a post hoc analysis of a multicenter, randomized trial comparing 3G-NBI, texture and color enhancement imaging, and white-light imaging in gastric neoplasm (GN) detection. For all detected lesions, the endoscopic diagnosis of ME using 3G-NBI was compared with the pathological diagnosis. The primary analyses focused on the sensitivity and specificity of ME with 3G-NBI for EGC or non-EGC. The diagnostic performance was analyzed according to confidence level, macroscopic type, lesion size, and\n                      <jats:italic>H. pylori<\/jats:italic>\n                      infection status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study included 901 patients; 228 suspected GN lesions in 187 patients were analyzed. The lesions were diagnosed with EGC in 62 (27 with high confidence) and non-EGC in 166 (91 with high confidence) patients using ME with 3G-NBI and pathologically diagnosed as EGC in 61 and non-EGC in 167 patients. The overall diagnostic performance was sensitivity and specificity of 70.5% and 88.6%, respectively. The diagnostic performance of each category was as follows: (1) confidence level (high\/low); sensitivity 78.1%\/62.1%, specificity 97.7%\/79.0%; (2) macroscopic type (elevated\/flat or depressed); sensitivity 84.6%\/66.7%, specificity 96.7%\/86.9%; (3) lesion diameter (&lt;\u200910\u00a0mm\/\u2009\u2265\u200910\u00a0mm); sensitivity 65.7%\/76.9%, specificity 88.6%\/88.9%; (4)\n                      <jats:italic>H. pylori<\/jats:italic>\n                      infection status (uninfected\/previously infected\/currently infected); sensitivity 50.0%\/71.0%\/86.7%, specificity 91.3%\/88.2%\/88.9%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The diagnostic performance of ME with 3G-NBI for EGC was acceptable, primarily in patients with\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration:<\/jats:title>\n                    <jats:p>This trial was registered in jRCT (Identifier jRCT1032210213).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00535-026-02434-0","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:23:15Z","timestamp":1778754195000},"page":"1093-1103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic performance of magnifying endoscopy with third-generation narrow-band imaging for early gastric cancer: post hoc analysis of a randomized trial (3G detection trial)"],"prefix":"10.1007","volume":"61","author":[{"given":"Nobuhisa","family":"Minakata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0408-3494","authenticated-orcid":false,"given":"Tomohiro","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriya","family":"Uedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Doyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Furue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikatoshi","family":"Katada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ikeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"2434_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2434_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"CTV Di AllemaniMatsudaCarlo","year":"2018","unstructured":"Di AllemaniMatsudaCarlo CTV, et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023\u201375.","journal-title":"Lancet"},{"key":"2434_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1053\/j.gastro.2018.04.026","volume":"155","author":"X Zhang","year":"2018","unstructured":"Zhang X, Li M, Chen S, et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: A meta-analysis and systematic review. Gastroenterology. 2018;155:347-54.e9.","journal-title":"Gastroenterology"},{"key":"2434_CR4","volume":"35","author":"M Hibino","year":"2023","unstructured":"Hibino M, Hamashima C, Iwata M, et al. Radiographic and endoscopic screening to reduce gastric cancer mortality: A systematic review and meta-analysis. Lancet Reg Health West Pac. 2023;35:100741.","journal-title":"Lancet Reg Health West Pac"},{"key":"2434_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1053\/j.gastro.2023.11.286","volume":"166","author":"D Sun","year":"2024","unstructured":"Sun D, M\u00fclder DT, Li Y, et al. The effect of nationwide organized cancer screening programs on gastric cancer mortality: A synthetic control study. Gastroenterology. 2024;166:503\u201314.","journal-title":"Gastroenterology"},{"key":"2434_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00535-020-01734-3","volume":"55","author":"N Kakushima","year":"2020","unstructured":"Kakushima N, Yoshida N, Doyama H, et al. Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial. J Gastroenterol. 2020;55:1127\u201337.","journal-title":"J Gastroenterol"},{"key":"2434_CR7","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1053\/j.gastro.2011.08.007","volume":"141","author":"Y Ezoe","year":"2011","unstructured":"Ezoe Y, Muto M, Uedo N, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141:2017-25.e3.","journal-title":"Gastroenterology"},{"key":"2434_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10120-013-0332-0","volume":"17","author":"K Yao","year":"2014","unstructured":"Yao K, Doyama H, Gotoda T, et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: A prospective multicenter feasibility study. Gastric Cancer. 2014;17:669\u201379.","journal-title":"Gastric Cancer"},{"key":"2434_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.gie.2013.07.008","volume":"79","author":"S Yamada","year":"2014","unstructured":"Yamada S, Doyama H, Yao K, et al. An efficient diagnostic strategy for small, depressed early gastric cancer with magnifying narrow-band imaging: A post-hoc analysis of a prospective randomized controlled trial. Gastrointest Endosc. 2014;79:55\u201363.","journal-title":"Gastrointest Endosc"},{"key":"2434_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","volume":"372","author":"K Fukase","year":"2008","unstructured":"Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet. 2008;372:392\u20137.","journal-title":"Lancet"},{"key":"2434_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-015855","volume":"7","author":"S Hiroi","year":"2017","unstructured":"Hiroi S, Sugano K, Tanaka S, et al. Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: Retrospective observational study and simulation study based on real-world data. BMJ Open. 2017;7:e015855.","journal-title":"BMJ Open"},{"key":"2434_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2036.2005.02360.x","volume":"21","author":"M Ito","year":"2005","unstructured":"Ito M, Tanaka S, Takata S, et al. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther. 2005;21:559\u201366.","journal-title":"Aliment Pharmacol Ther"},{"key":"2434_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s10120-015-0479-y","volume":"19","author":"A Saka","year":"2016","unstructured":"Saka A, Yagi K, Nimura S. Nimura. endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer. 2016;19:524\u201330.","journal-title":"Gastric Cancer"},{"key":"2434_CR14","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00535-013-0764-7","volume":"48","author":"M Kobayashi","year":"2013","unstructured":"Kobayashi M, Hashimoto S, Nishikura K, et al. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. J Gastroenterol. 2013;48:1332\u201342.","journal-title":"J Gastroenterol"},{"key":"2434_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1055\/s-0029-1214594","volume":"41","author":"K Yao","year":"2009","unstructured":"Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41:462\u20137.","journal-title":"Endoscopy"},{"key":"2434_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/den.12638","volume":"28","author":"M Muto","year":"2016","unstructured":"Muto M, Yao K, Kaise M, et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig Endosc. 2016;28:379\u201393.","journal-title":"Dig Endosc"},{"key":"2434_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.gie.2010.04.041","volume":"72","author":"M Kato","year":"2010","unstructured":"Kato M, Kaise M, Yonezawa J, et al. Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc. 2010;72:523\u20139.","journal-title":"Gastrointest Endosc"},{"key":"2434_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5518948","volume":"2021","author":"T Sato","year":"2021","unstructured":"Sato T. TXI: texture and color enhancement imaging for endoscopic image enhancement. J Healthc Eng. 2021;2021:5518948.","journal-title":"J Healthc Eng"},{"key":"2434_CR19","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.14309\/ajg.0000000000002871","volume":"119","author":"T Kadota","year":"2024","unstructured":"Kadota T, Abe S, Uedo N, et al. Comparison of effective imaging modalities for detecting gastric neoplasms: A randomized 3-arm phase II trial. Am J Gastroenterol. 2024;119:2010\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"2434_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1443-1661.2012.01407.x","volume":"25","author":"C Katada","year":"2013","unstructured":"Katada C, Muto M, Tanabe S, et al. Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinoma. Dig Endosc. 2013;25(Suppl 1):39\u201343.","journal-title":"Dig Endosc"},{"key":"2434_CR21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s10120-023-01413-1","volume":"26","author":"M Hirao","year":"2023","unstructured":"Hirao M, Katada C, Yokoyama T, et al. Metachronous primary gastric cancer after endoscopic resection in patients with esophageal squamous cell carcinoma. Gastric Cancer. 2023;26:988\u20131001.","journal-title":"Gastric Cancer"},{"key":"2434_CR22","volume-title":"Japanese classification of gastric carcinoma","author":"Japanese Gastric Cancer Association","year":"2017","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 15th Edition. Tokyo: Kanehara Publishing; 2017.","edition":"15th Edition"},{"key":"2434_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/gut.51.1.130","volume":"51","author":"MF Dixon","year":"2002","unstructured":"Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002;51:130\u20131.","journal-title":"Gut"},{"key":"2434_CR24","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3748\/wjg.v28.i48.6900","volume":"28","author":"S Kinami","year":"2022","unstructured":"Kinami S, Yamada S, Takamura H. Confusion and prospects for carcinogenesis of gastric adenoma and dysplasia: what is the correct answer currently? World J Gastroenterol. 2022;28:6900\u20138.","journal-title":"World J Gastroenterol"},{"key":"2434_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s10120-011-0093-6","volume":"15","author":"K Miwa","year":"2012","unstructured":"Miwa K, Doyama H, Ito R, et al. Can magnifying endoscopy with narrow band imaging be useful for low grade adenomas in preoperative biopsy specimens? Gastric Cancer. 2012;15:170\u20138.","journal-title":"Gastric Cancer"},{"key":"2434_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s10120-011-0133-2","volume":"15","author":"Y Tsuji","year":"2012","unstructured":"Tsuji Y, Ohata K, Sekiguchi M, et al. Magnifying endoscopy with narrow-band imaging helps determine the management of gastric adenomas. Gastric Cancer. 2012;15:414\u20138.","journal-title":"Gastric Cancer"},{"key":"2434_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s10120-012-0160-7","volume":"16","author":"S Maki","year":"2013","unstructured":"Maki S, Yao K, Nagahama T, et al. Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions. Gastric Cancer. 2013;16:140\u20136.","journal-title":"Gastric Cancer"},{"key":"2434_CR28","doi-asserted-by":"publisher","first-page":"e12597","DOI":"10.1111\/hel.12597","volume":"24","author":"M Kato","year":"2019","unstructured":"Kato M, Ota H, Okuda M, et al. Guidelines for the management of Helicobacter pylori infection in Japan Revised Edition 2016. Helicobacter. 2019;24:e12597.","journal-title":"Helicobacter"},{"key":"2434_CR29","doi-asserted-by":"publisher","first-page":"E1203","DOI":"10.1055\/s-0042-117632","volume":"4","author":"T Nonaka","year":"2016","unstructured":"Nonaka T, Inamori M, Honda Y, et al. Can magnifying endoscopy with narrow-band imaging discriminate between carcinomas and low grade adenomas in gastric superficial elevated lesions? Endosc Int Open. 2016;4:E1203\u201310.","journal-title":"Endosc Int Open"},{"key":"2434_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032881","volume":"102","author":"Y Umeda","year":"2023","unstructured":"Umeda Y, Tanaka K, Ikenoyama Y, et al. The usefulness of image-enhanced endoscopy to distinguish gastric carcinoma in tumors initially diagnosed as adenomas by endoscopic biopsy: A retrospective study. Medicine (Baltimore). 2023;102:e32881.","journal-title":"Medicine (Baltimore)"},{"key":"2434_CR31","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.cgh.2013.03.019","volume":"11","author":"YH Shaib","year":"2013","unstructured":"Shaib YH, Rugge M, Graham DY, et al. Management of gastric polyps: An endoscopy-based approach. Clin Gastroenterol Hepatol. 2013;11:1374\u201384.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2434_CR32","first-page":"203","volume":"4","author":"N Nagata","year":"2011","unstructured":"Nagata N, Shimbo T, Akiyama J, et al. Predictability of gastric intestinal metaplasia by mottled patchy erythema seen on endoscopy. Gastroenterology Res. 2011;4:203\u20139.","journal-title":"Gastroenterology Res"},{"key":"2434_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/den.12581","volume":"28","author":"K Moribata","year":"2016","unstructured":"Moribata K, Iguchi JK, Nakachi K, et al. Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication. Dig Endosc. 2016;28:434\u201342.","journal-title":"Dig Endosc"},{"key":"2434_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/den.14114","volume":"34","author":"M Kawamura","year":"2022","unstructured":"Kawamura M, Uedo N, Koike T, et al. Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan. Dig Endosc. 2022;34:508\u201316.","journal-title":"Dig Endosc"},{"key":"2434_CR35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.5009\/gnl19418","volume":"15","author":"M Ito","year":"2021","unstructured":"Ito M, Tanaka S, Chayama K. Characteristics and early diagnosis of gastric cancer discovered after Helicobacter pylori eradication. Gut Liver. 2021;15:338\u201345.","journal-title":"Gut Liver"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02434-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:07:23Z","timestamp":1785514043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02434-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2434"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02434-0","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.Y. received a research grant from Olympus as a principal investigator. S.A., N.U., H.D., Y.F., and M.M. received research grants from Olympus as facility study managers. T.K. received honoraria and personal advisory fees from Olympus outside this study. S.A. received personal fees from Boston Scientific, personal fees and research funding from FUJIFILM, and personal fees and research funding from Olympus. N.U. received honoraria for lectures from Olympus Co., Ltd., FUJIFILM Co., Ltd., Boston Scientific, Japan, and AI Medical Service Co., Ltd. H.D. received honoraria for lectures at Olympus. S.N. has received honoraria for lectures at Olympus, Japan. T.Y. received honoraria for lectures and research grants from Olympus and research grants from HOYA PENTAX and FUJIFILM. N.M., Y.T., N.Y., C.K., A.Y., T.I., and M.W. have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the ethical standards established by the Declaration of Helsinki and Clinical Trials Act. The National Cancer Center Hospital East Certified Review Board approved the study protocol in June 2021. All patients provided written informed consent prior to participation. This trial was registered in jRCT (Identifier jRCT1032210213).","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}